INTERACTIVE CD-ROM FOR COPING WITH DEPRESSION

这个项目进一步发展和评估了一个教学光盘产品，态度增强工作坊，用来教授应对抑郁的技巧。该产品通过扩展内容、增强交互性和多媒体组件，扩展了第一阶段原型所展示的前景。抑郁症的流行和影响表明需要低成本、可获得的干预措施。数字技术使个性化的、引人入胜的和有效的学习经验的高效大规模传播成为可能。态度增强工作坊，基于Peter Lewinsohn博士和他的同事开发的应对抑郁干预，已经被经验证明在缓解抑郁方面是有效的。一个新的模块，体力活动，将被添加，以回应体力活动改善情绪的功效。该产品将适合通过健康和精神卫生保健机构、健康维护组织、健康保险公司和员工援助计划进行大规模分发。此外，将编制多媒体训练材料，向向最终用户开处方的专业人员提供指导。将通过测量在初级卫生保健机构提供的“常规护理”抑郁症干预措施一年期间的附加价值来研究该产品的功效。拟议的商业应用：该研究将评估一种交互式CD-ROM产品的功效，该产品有可能帮助美国数千万患有抑郁症或抑郁症状的人。该产品将适合通过已建立的心理健康和卫生保健机构进行分销，包括健康维护组织、初级保健诊所、员工援助计划和健康保险组织。

This project further develops and evaluates an instructional CD-ROM product, the Attitude mPowerment Workshop, for teaching coping skills for managing depression. The product extends the demonstrated promise of the Phase I prototype by broadening the content and enhancing the interactivity and multimedia components. The prevalence and impact of depressive illness demonstrates the need for low cost, accessible interventions. Digital technology makes possible efficient mass distribution of an individualized, engaging and effective learning experience. The Attitude mPowerment Workshop, based on the Coping With Depression intervention developed by Dr. Peter Lewinsohn and his Associates, has been empirically validated as effective in alleviating depression. A new module, Physical Activity, will be added in response to the demonstrated efficacy of physical activity for improving mood. The product will be suitable for mass distribution through health and mental health care institutions, health maintenance organizations, health insurance companies and employee assistance programs. In addition, multimedia training materials will be developed to provide instruction to professionals who prescribe the product to end-users. The efficacy of the product will be studied by measuring its added value over a one year period to a "usual care" depression intervention provided in primary health care settings. PROPOSED COMMERCIAL APPLICATION: The research will evaluate the efficacy of an interactive CD-ROM product that can potentially assist tens of millions of people in the United States who suffer from depression or depressive symptoms. The product will be appropriate for distribution through established mental health and health care institutions, including health maintenance organizations, primary care clinics, employee assistance programs and health insurance organizations.